Dysregulated ARID1A expression can be detected in multiple malignancies, including gastric cancer, bladder cancer, and especially LUAD, ARID1A loss is associated with the significant enhancement of tumor metastasis and a poor prognosis [7]. This evidence concerns the gene ARID1A and urinary bladder carcinoma.